Literature DB >> 18456776

Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up.

E Zucca1, M Dreyling.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18456776     DOI： 10.1093/annonc/mdn094

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

1.  Gastric mucosa-associated lymphoid tissue lymphomas and Helicobacter pylori infection: a Colombian perspective.

Authors:  Sally Yepes; Maria Mercedes Torres; Carlos Saavedra; Rafael Andrade
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

2.  A Case of Pulmonary MALT Lymphoma Arising from Lymphocytic Interstitial Pneumonitis.

Authors:  Ki Hoon Park; Soon Seog Kwon; Myung Hee Chung; Jeana Kim; Hee Jung Lee; Ji-Won Min; Yong Hyun Kim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-08-31

3.  Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma.

Authors:  Hyung Soon Park; Yu Jin Kim; Woo Ick Yang; Chang Ok Suh; Yong Chan Lee
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

Review 4.  Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development.

Authors:  Xavier Sagaert; Eric Van Cutsem; Gert De Hertogh; Karel Geboes; Thomas Tousseyn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05-04       Impact factor: 46.802

5.  Gastric low-grade mucosal-associated lymphoid tissue-lymphoma: Helicobacter pylori and beyond.

Authors:  Angelo Zullo; Cesare Hassan; Francesca Cristofari; Francesco Perri; Sergio Morini
Journal:  World J Gastrointest Oncol       Date:  2010-04-15

Review 6.  Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy: a pooled-data analysis.

Authors:  Angelo Zullo; Cesare Hassan; Alessandro Andriani; Francesca Cristofari; Chiara Bassanelli; Gian Paolo Spinelli; Silverio Tomao; Sergio Morini
Journal:  Med Oncol       Date:  2009-03-24       Impact factor: 3.064
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.